Figure 1
From: Lack of tocilizumab effect on mortality in COVID19 patients
Cox regression showing no statistical difference in mortality between COVID 19 subjects treated and untreated tocilizumab therapy. Blue: shows treated with Tocilizuman, Black: shows untreated with Tocilizumab. Variables in the model: Age >  = 75, IL6 >  = 580, and Tocilizumab. p value, HR (95%CI) for Tocilizumab: 0.75, 0.9 (0.3–2.2).
